Key Takeaways
- HubSpot shares declined over 24% during Friday’s premarket session following Q1 earnings release
- Q1 revenue reached $881M, surpassing analyst projections, while forward outlook fell below expectations
- Cantor Fitzgerald and William Blair issued downgrades on the stock
- Extended sales cycles and sales team retraining disruptions impacted future projections
- Morgan Stanley reduced its price objective from $405 to $350 while keeping an Overweight stance
HubSpot (HUBS) experienced a steep decline exceeding 24% during Friday’s premarket hours, with shares opening at $243.74, as the marketing software company’s quarterly report sparked concerns among investors regarding future performance expectations.
The company’s core Q1 metrics painted an encouraging picture. Revenue totaled $881 million, representing a 23% year-over-year increase and surpassing the $863 million analyst consensus. Earnings per share of $2.72 exceeded projections of $2.47 by $0.25. The operating margin reached 17.8%, outperforming expectations by 100 basis points.
The source of investor concern centered on forward-looking projections.
HubSpot’s annual revenue forecast disappointed Wall Street by failing to incorporate the full Q1 outperformance. Cantor Fitzgerald analysts observed that management only incorporated approximately two-thirds of the first-quarter success into their FY26 projections. This approach makes the high-teens to approximately 20% constant-currency expansion that many market participants anticipated appear increasingly unlikely.
Cantor downgraded its rating to Neutral from Overweight and reduced its price objective from $325 to $200. William Blair shifted to Market Perform from Outperform.
Sales Team Changes Created Additional Headwinds
Complications emerged at the beginning of Q2. The company invested roughly one week during April retraining its sales organization following modifications connected to its Spring Spotlight product rollout. This temporary interruption hampered early momentum in the second quarter.
Leadership also highlighted lengthening sales cycles as a challenge. Cantor analysts characterized many of these factors as “self-inflicted choices” designed to deliver longer-term advantages, while acknowledging they will likely pressure growth metrics over the coming quarters.
Morgan Stanley maintained its Overweight recommendation while lowering its price objective from $405 to $350. Wells Fargo, Needham, Stifel, and Citigroup similarly reduced their targets. Needham made the most significant adjustment, decreasing from $700 to $300 while preserving a Buy recommendation.
Current Analyst Sentiment
The overall analyst community maintains a cautiously optimistic outlook. Among the 29 analysts monitored by MarketBeat, 23 assign a Buy rating, four recommend a Hold, and two suggest a Sell. The mean price target stands at $365.96 — significantly above current trading levels.
HubSpot reached a 52-week high of $682.57. The stock touched a low of $187.45 during that same timeframe.
For Q2 2026, management provided EPS guidance of $3.00 to $3.02. Annual EPS projections range from $13.04 to $13.12.
Insider transactions have drawn attention recently. Director Brian Halligan divested 8,500 shares during March at $262.75. Insider Erika Ashley Fisher sold 915 shares on May 4th at $236.66, with the transaction linked to tax requirements from equity vesting.
Regarding institutional activity, T. Rowe Price expanded its position by 36.5% in Q4, while AQR Capital Management increased its holdings by 117.6%. Institutional ownership accounts for 90.39% of outstanding shares.
HUBS carries a market capitalization of $12.55 billion and trades at a P/E ratio of 280.16.
